Global Human Organs-on-Chips Supply, Demand and Key Producers, 2024-2030

Description

An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels. The primary focus of Organ-On-Chip technology is the re-creation of three key aspects of human physiology: the multicellular vascular or epithelial interfaces of organs (for example, blood vessel networks, lung and gut), which function as barriers in tissues; the tissue-level organization of parenchymal cells (for example, liver, heart, skeletal muscle and tumours), which are responsible for the key functional properties of an organ; and the systematic interaction of multiple organs (for example, drug absorption, distribution, metabolism and elimination involving the gut, circulation, liver and kidney). In addition, the Blood-Brain Barrier is definitely more complex than a simple wall, controlling the passage of most solute that enters or leaves the brain. To address how this molecular sieve affects neural activity, some researchers have simulated the interaction between blood vessels and brain tissue on a series of interconnected "organ chips" when connected through this Blood-Brain Barrier (BBB) model. Endothelial cells, pericytes, astrocytes and neurons alter their gene expression. These technologies will achieve even more rapid development and application.

The global Human Organs-on-Chips market size is expected to reach $ 792 million by 2030, rising at a market growth of 30.5% CAGR during the forecast period (2024-2030).

Global key players of Human Organs-on-Chips include Emulate, Mimetas, TissUse, Valo Health and CN Bio Innovations. The top five players hold a share over 55%. North America is the largest market, has a share about 42%, followed by Europe, and Asia-Pacific, with share 35% and 18%, separately. In terms of product type, Liver-on-a-chip is the largest segment, occupied for a share of 26%, and in terms of application, Pharmaceutical & Biotechnology Companies has a share about 70%.

This report studies the global Human Organs-on-Chips demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Human Organs-on-Chips, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Organs-on-Chips that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Human Organs-on-Chips total market, 2019-2030, (USD Million)
Global Human Organs-on-Chips total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Human Organs-on-Chips total market, key domestic companies, and share, (USD Million)
Global Human Organs-on-Chips revenue by player, revenue and market share 2019-2024, (USD Million)
Global Human Organs-on-Chips total market by Type, CAGR, 2019-2030, (USD Million)
Global Human Organs-on-Chips total market by End User, CAGR, 2019-2030, (USD Million)
This report profiles major players in the global Human Organs-on-Chips market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Emulate, Mimetas, TissUse, Valo Health, CN Bio Innovations, Hesperos, Draper Laboratory, Nortis, Micronit Microtechnologies B.V., Kirkstall, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Human Organs-on-Chips market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by End User. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Human Organs-on-Chips Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Human Organs-on-Chips Market, Segmentation by Type
    Brain-on-a-chip
    Liver-on-a-chip
    Kidney-on-a-chip
    Lung-on-a-chip
    Heart-on-a-chip
    Intestine-on-a-chip
    Vessel-on-a-chip
    Other Organs

Global Human Organs-on-Chips Market, Segmentation by End User:
    Pharmaceutical & Biotechnology Companies
    Academic & Research Institutes
    Cosmetics Industry
    Others

Companies Profiled:
    Emulate
    Mimetas
    TissUse
    Valo Health
    CN Bio Innovations
    Hesperos
    Draper Laboratory
    Nortis
    Micronit Microtechnologies B.V.
    Kirkstall
    Cherry Biotech SAS
    Else Kooi Laboratory
    Altis Biosystems
    Bi/ond
    Netri
    Xona Microfluidics
    SynVivo
    Beijing Daxiang Biotech
    AVATARGET
    Suzhou Jiyan Biopharmaceutical

Key Questions Answered
1. How big is the global Human Organs-on-Chips market?
2. What is the demand of the global Human Organs-on-Chips market?
3. What is the year over year growth of the global Human Organs-on-Chips market?
4. What is the total value of the global Human Organs-on-Chips market?
5. Who are the Major Players in the global Human Organs-on-Chips market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Human Organs-on-Chips Introduction
    1.2 World Human Organs-on-Chips Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Human Organs-on-Chips Total Market by Region (by Headquarter Location)
        1.3.1 World Human Organs-on-Chips Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Based Company Human Organs-on-Chips Revenue (2019-2030)
        1.3.3 China Based Company Human Organs-on-Chips Revenue (2019-2030)
        1.3.4 Europe Based Company Human Organs-on-Chips Revenue (2019-2030)
        1.3.5 Japan Based Company Human Organs-on-Chips Revenue (2019-2030)
        1.3.6 South Korea Based Company Human Organs-on-Chips Revenue (2019-2030)
        1.3.7 ASEAN Based Company Human Organs-on-Chips Revenue (2019-2030)
        1.3.8 India Based Company Human Organs-on-Chips Revenue (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Human Organs-on-Chips Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Major Market Trends

2 Demand Summary
    2.1 World Human Organs-on-Chips Consumption Value (2019-2030)
    2.2 World Human Organs-on-Chips Consumption Value by Region
        2.2.1 World Human Organs-on-Chips Consumption Value by Region (2019-2024)
        2.2.2 World Human Organs-on-Chips Consumption Value Forecast by Region (2025-2030)
    2.3 United States Human Organs-on-Chips Consumption Value (2019-2030)
    2.4 China Human Organs-on-Chips Consumption Value (2019-2030)
    2.5 Europe Human Organs-on-Chips Consumption Value (2019-2030)
    2.6 Japan Human Organs-on-Chips Consumption Value (2019-2030)
    2.7 South Korea Human Organs-on-Chips Consumption Value (2019-2030)
    2.8 ASEAN Human Organs-on-Chips Consumption Value (2019-2030)
    2.9 India Human Organs-on-Chips Consumption Value (2019-2030)

3 World Human Organs-on-Chips Companies Competitive Analysis
    3.1 World Human Organs-on-Chips Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Human Organs-on-Chips Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Human Organs-on-Chips in 2023
        3.2.3 Global Concentration Ratios (CR8) for Human Organs-on-Chips in 2023
    3.3 Human Organs-on-Chips Company Evaluation Quadrant
    3.4 Human Organs-on-Chips Market: Overall Company Footprint Analysis
        3.4.1 Human Organs-on-Chips Market: Region Footprint
        3.4.2 Human Organs-on-Chips Market: Company Product Type Footprint
        3.4.3 Human Organs-on-Chips Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)
    4.1 United States VS China: Human Organs-on-Chips Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Human Organs-on-Chips Revenue Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Human Organs-on-Chips Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Human Organs-on-Chips Consumption Value Comparison
        4.2.1 United States VS China: Human Organs-on-Chips Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Human Organs-on-Chips Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Human Organs-on-Chips Companies and Market Share, 2019-2024
        4.3.1 United States Based Human Organs-on-Chips Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Human Organs-on-Chips Revenue, (2019-2024)
    4.4 China Based Companies Human Organs-on-Chips Revenue and Market Share, 2019-2024
        4.4.1 China Based Human Organs-on-Chips Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Human Organs-on-Chips Revenue, (2019-2024)
    4.5 Rest of World Based Human Organs-on-Chips Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Human Organs-on-Chips Companies, Headquarters (Province, Country)
        4.5.2 Rest of World Based Companies Human Organs-on-Chips Revenue (2019-2024)

5 Market Analysis by Type
    5.1 World Human Organs-on-Chips Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Brain-on-a-chip
        5.2.2 Liver-on-a-chip
        5.2.3 Kidney-on-a-chip
        5.2.4 Lung-on-a-chip
        5.2.5 Heart-on-a-chip
        5.2.6 Intestine-on-a-chip
        5.2.7 Vessel-on-a-chip
        5.2.8 Other Organs
    5.3 Market Segment by Type
        5.3.1 World Human Organs-on-Chips Market Size by Type (2019-2024)
        5.3.2 World Human Organs-on-Chips Market Size by Type (2025-2030)
        5.3.3 World Human Organs-on-Chips Market Size Market Share by Type (2025-2030)

6 Market Analysis by End User
    6.1 World Human Organs-on-Chips Market Size Overview by End User: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by End User
        6.2.1 Pharmaceutical & Biotechnology Companies
        6.2.2 Academic & Research Institutes
        6.2.3 Cosmetics Industry
        6.2.4 Others
    6.3 Market Segment by End User
        6.3.1 World Human Organs-on-Chips Market Size by End User (2019-2024)
        6.3.2 World Human Organs-on-Chips Market Size by End User (2025-2030)
        6.3.3 World Human Organs-on-Chips Market Size Market Share by End User (2019-2030)

7 Company Profiles
    7.1 Emulate
        7.1.1 Emulate Details
        7.1.2 Emulate Major Business
        7.1.3 Emulate Human Organs-on-Chips Product and Services
        7.1.4 Emulate Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Emulate Recent Developments/Updates
        7.1.6 Emulate Competitive Strengths & Weaknesses
    7.2 Mimetas
        7.2.1 Mimetas Details
        7.2.2 Mimetas Major Business
        7.2.3 Mimetas Human Organs-on-Chips Product and Services
        7.2.4 Mimetas Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Mimetas Recent Developments/Updates
        7.2.6 Mimetas Competitive Strengths & Weaknesses
    7.3 TissUse
        7.3.1 TissUse Details
        7.3.2 TissUse Major Business
        7.3.3 TissUse Human Organs-on-Chips Product and Services
        7.3.4 TissUse Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 TissUse Recent Developments/Updates
        7.3.6 TissUse Competitive Strengths & Weaknesses
    7.4 Valo Health
        7.4.1 Valo Health Details
        7.4.2 Valo Health Major Business
        7.4.3 Valo Health Human Organs-on-Chips Product and Services
        7.4.4 Valo Health Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Valo Health Recent Developments/Updates
        7.4.6 Valo Health Competitive Strengths & Weaknesses
    7.5 CN Bio Innovations
        7.5.1 CN Bio Innovations Details
        7.5.2 CN Bio Innovations Major Business
        7.5.3 CN Bio Innovations Human Organs-on-Chips Product and Services
        7.5.4 CN Bio Innovations Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 CN Bio Innovations Recent Developments/Updates
        7.5.6 CN Bio Innovations Competitive Strengths & Weaknesses
    7.6 Hesperos
        7.6.1 Hesperos Details
        7.6.2 Hesperos Major Business
        7.6.3 Hesperos Human Organs-on-Chips Product and Services
        7.6.4 Hesperos Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Hesperos Recent Developments/Updates
        7.6.6 Hesperos Competitive Strengths & Weaknesses
    7.7 Draper Laboratory
        7.7.1 Draper Laboratory Details
        7.7.2 Draper Laboratory Major Business
        7.7.3 Draper Laboratory Human Organs-on-Chips Product and Services
        7.7.4 Draper Laboratory Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Draper Laboratory Recent Developments/Updates
        7.7.6 Draper Laboratory Competitive Strengths & Weaknesses
    7.8 Nortis
        7.8.1 Nortis Details
        7.8.2 Nortis Major Business
        7.8.3 Nortis Human Organs-on-Chips Product and Services
        7.8.4 Nortis Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Nortis Recent Developments/Updates
        7.8.6 Nortis Competitive Strengths & Weaknesses
    7.9 Micronit Microtechnologies B.V.
        7.9.1 Micronit Microtechnologies B.V. Details
        7.9.2 Micronit Microtechnologies B.V. Major Business
        7.9.3 Micronit Microtechnologies B.V. Human Organs-on-Chips Product and Services
        7.9.4 Micronit Microtechnologies B.V. Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Micronit Microtechnologies B.V. Recent Developments/Updates
        7.9.6 Micronit Microtechnologies B.V. Competitive Strengths & Weaknesses
    7.10 Kirkstall
        7.10.1 Kirkstall Details
        7.10.2 Kirkstall Major Business
        7.10.3 Kirkstall Human Organs-on-Chips Product and Services
        7.10.4 Kirkstall Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Kirkstall Recent Developments/Updates
        7.10.6 Kirkstall Competitive Strengths & Weaknesses
    7.11 Cherry Biotech SAS
        7.11.1 Cherry Biotech SAS Details
        7.11.2 Cherry Biotech SAS Major Business
        7.11.3 Cherry Biotech SAS Human Organs-on-Chips Product and Services
        7.11.4 Cherry Biotech SAS Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Cherry Biotech SAS Recent Developments/Updates
        7.11.6 Cherry Biotech SAS Competitive Strengths & Weaknesses
    7.12 Else Kooi Laboratory
        7.12.1 Else Kooi Laboratory Details
        7.12.2 Else Kooi Laboratory Major Business
        7.12.3 Else Kooi Laboratory Human Organs-on-Chips Product and Services
        7.12.4 Else Kooi Laboratory Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 Else Kooi Laboratory Recent Developments/Updates
        7.12.6 Else Kooi Laboratory Competitive Strengths & Weaknesses
    7.13 Altis Biosystems
        7.13.1 Altis Biosystems Details
        7.13.2 Altis Biosystems Major Business
        7.13.3 Altis Biosystems Human Organs-on-Chips Product and Services
        7.13.4 Altis Biosystems Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 Altis Biosystems Recent Developments/Updates
        7.13.6 Altis Biosystems Competitive Strengths & Weaknesses
    7.14 Bi/ond
        7.14.1 Bi/ond Details
        7.14.2 Bi/ond Major Business
        7.14.3 Bi/ond Human Organs-on-Chips Product and Services
        7.14.4 Bi/ond Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 Bi/ond Recent Developments/Updates
        7.14.6 Bi/ond Competitive Strengths & Weaknesses
    7.15 Netri
        7.15.1 Netri Details
        7.15.2 Netri Major Business
        7.15.3 Netri Human Organs-on-Chips Product and Services
        7.15.4 Netri Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024)
        7.15.5 Netri Recent Developments/Updates
        7.15.6 Netri Competitive Strengths & Weaknesses
    7.16 Xona Microfluidics
        7.16.1 Xona Microfluidics Details
        7.16.2 Xona Microfluidics Major Business
        7.16.3 Xona Microfluidics Human Organs-on-Chips Product and Services
        7.16.4 Xona Microfluidics Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024)
        7.16.5 Xona Microfluidics Recent Developments/Updates
        7.16.6 Xona Microfluidics Competitive Strengths & Weaknesses
    7.17 SynVivo
        7.17.1 SynVivo Details
        7.17.2 SynVivo Major Business
        7.17.3 SynVivo Human Organs-on-Chips Product and Services
        7.17.4 SynVivo Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024)
        7.17.5 SynVivo Recent Developments/Updates
        7.17.6 SynVivo Competitive Strengths & Weaknesses
    7.18 Beijing Daxiang Biotech
        7.18.1 Beijing Daxiang Biotech Details
        7.18.2 Beijing Daxiang Biotech Major Business
        7.18.3 Beijing Daxiang Biotech Human Organs-on-Chips Product and Services
        7.18.4 Beijing Daxiang Biotech Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024)
        7.18.5 Beijing Daxiang Biotech Recent Developments/Updates
        7.18.6 Beijing Daxiang Biotech Competitive Strengths & Weaknesses
    7.19 AVATARGET
        7.19.1 AVATARGET Details
        7.19.2 AVATARGET Major Business
        7.19.3 AVATARGET Human Organs-on-Chips Product and Services
        7.19.4 AVATARGET Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024)
        7.19.5 AVATARGET Recent Developments/Updates
        7.19.6 AVATARGET Competitive Strengths & Weaknesses
    7.20 Suzhou Jiyan Biopharmaceutical
        7.20.1 Suzhou Jiyan Biopharmaceutical Details
        7.20.2 Suzhou Jiyan Biopharmaceutical Major Business
        7.20.3 Suzhou Jiyan Biopharmaceutical Human Organs-on-Chips Product and Services
        7.20.4 Suzhou Jiyan Biopharmaceutical Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024)
        7.20.5 Suzhou Jiyan Biopharmaceutical Recent Developments/Updates
        7.20.6 Suzhou Jiyan Biopharmaceutical Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Human Organs-on-Chips Industry Chain
    8.2 Human Organs-on-Chips Upstream Analysis
    8.3 Human Organs-on-Chips Midstream Analysis
    8.4 Human Organs-on-Chips Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Human Organs-on-Chips Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Table 2. World Human Organs-on-Chips Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
 Table 3. World Human Organs-on-Chips Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
 Table 4. World Human Organs-on-Chips Revenue Market Share by Region (2019-2024), (by Headquarter Location)
 Table 5. World Human Organs-on-Chips Revenue Market Share by Region (2025-2030), (by Headquarter Location)
 Table 6. Major Market Trends
 Table 7. World Human Organs-on-Chips Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
 Table 8. World Human Organs-on-Chips Consumption Value by Region (2019-2024) & (USD Million)
 Table 9. World Human Organs-on-Chips Consumption Value Forecast by Region (2025-2030) & (USD Million)
 Table 10. World Human Organs-on-Chips Revenue by Player (2019-2024) & (USD Million)
 Table 11. Revenue Market Share of Key Human Organs-on-Chips Players in 2023
 Table 12. World Human Organs-on-Chips Industry Rank of Major Player, Based on Revenue in 2023
 Table 13. Global Human Organs-on-Chips Company Evaluation Quadrant
 Table 14. Head Office of Key Human Organs-on-Chips Players
 Table 15. Human Organs-on-Chips Market: Company Product Type Footprint
 Table 16. Human Organs-on-Chips Market: Company Product Application Footprint
 Table 17. Human Organs-on-Chips Mergers & Acquisitions Activity
 Table 18. United States VS China Human Organs-on-Chips Revenue Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 19. United States VS China Human Organs-on-Chips Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 20. United States Based Human Organs-on-Chips Companies, Headquarters (States, Country)
 Table 21. United States Based Companies Human Organs-on-Chips Revenue, (2019-2024) & (USD Million)
 Table 22. United States Based Companies Human Organs-on-Chips Revenue Market Share (2019-2024)
 Table 23. China Based Human Organs-on-Chips Companies, Headquarters (Province, Country)
 Table 24. China Based Companies Human Organs-on-Chips Revenue, (2019-2024) & (USD Million)
 Table 25. China Based Companies Human Organs-on-Chips Revenue Market Share (2019-2024)
 Table 26. Rest of World Based Human Organs-on-Chips Companies, Headquarters (Province, Country)
 Table 27. Rest of World Based Companies Human Organs-on-Chips Revenue (2019-2024) & (USD Million)
 Table 28. Rest of World Based Companies Human Organs-on-Chips Revenue Market Share (2019-2024)
 Table 29. World Human Organs-on-Chips Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Table 30. World Human Organs-on-Chips Market Size Value by Type (2019-2024) & (USD Million)
 Table 31. World Human Organs-on-Chips Market Size by Type (2025-2030) & (USD Million)
 Table 32. World Human Organs-on-Chips Market Size by End User, (USD Million), 2019 & 2023 & 2030
 Table 33. World Human Organs-on-Chips Market Size by End User (2019-2024) & (USD Million)
 Table 34. World Human Organs-on-Chips Market Size by End User (2025-2030) & (USD Million)
 Table 35. Emulate Basic Information, Manufacturing Base and Competitors
 Table 36. Emulate Major Business
 Table 37. Emulate Human Organs-on-Chips Product and Services
 Table 38. Emulate Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 39. Emulate Recent Developments/Updates
 Table 40. Emulate Competitive Strengths & Weaknesses
 Table 41. Mimetas Basic Information, Manufacturing Base and Competitors
 Table 42. Mimetas Major Business
 Table 43. Mimetas Human Organs-on-Chips Product and Services
 Table 44. Mimetas Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 45. Mimetas Recent Developments/Updates
 Table 46. Mimetas Competitive Strengths & Weaknesses
 Table 47. TissUse Basic Information, Manufacturing Base and Competitors
 Table 48. TissUse Major Business
 Table 49. TissUse Human Organs-on-Chips Product and Services
 Table 50. TissUse Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 51. TissUse Recent Developments/Updates
 Table 52. TissUse Competitive Strengths & Weaknesses
 Table 53. Valo Health Basic Information, Manufacturing Base and Competitors
 Table 54. Valo Health Major Business
 Table 55. Valo Health Human Organs-on-Chips Product and Services
 Table 56. Valo Health Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 57. Valo Health Recent Developments/Updates
 Table 58. Valo Health Competitive Strengths & Weaknesses
 Table 59. CN Bio Innovations Basic Information, Manufacturing Base and Competitors
 Table 60. CN Bio Innovations Major Business
 Table 61. CN Bio Innovations Human Organs-on-Chips Product and Services
 Table 62. CN Bio Innovations Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 63. CN Bio Innovations Recent Developments/Updates
 Table 64. CN Bio Innovations Competitive Strengths & Weaknesses
 Table 65. Hesperos Basic Information, Manufacturing Base and Competitors
 Table 66. Hesperos Major Business
 Table 67. Hesperos Human Organs-on-Chips Product and Services
 Table 68. Hesperos Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 69. Hesperos Recent Developments/Updates
 Table 70. Hesperos Competitive Strengths & Weaknesses
 Table 71. Draper Laboratory Basic Information, Manufacturing Base and Competitors
 Table 72. Draper Laboratory Major Business
 Table 73. Draper Laboratory Human Organs-on-Chips Product and Services
 Table 74. Draper Laboratory Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 75. Draper Laboratory Recent Developments/Updates
 Table 76. Draper Laboratory Competitive Strengths & Weaknesses
 Table 77. Nortis Basic Information, Manufacturing Base and Competitors
 Table 78. Nortis Major Business
 Table 79. Nortis Human Organs-on-Chips Product and Services
 Table 80. Nortis Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 81. Nortis Recent Developments/Updates
 Table 82. Nortis Competitive Strengths & Weaknesses
 Table 83. Micronit Microtechnologies B.V. Basic Information, Manufacturing Base and Competitors
 Table 84. Micronit Microtechnologies B.V. Major Business
 Table 85. Micronit Microtechnologies B.V. Human Organs-on-Chips Product and Services
 Table 86. Micronit Microtechnologies B.V. Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 87. Micronit Microtechnologies B.V. Recent Developments/Updates
 Table 88. Micronit Microtechnologies B.V. Competitive Strengths & Weaknesses
 Table 89. Kirkstall Basic Information, Manufacturing Base and Competitors
 Table 90. Kirkstall Major Business
 Table 91. Kirkstall Human Organs-on-Chips Product and Services
 Table 92. Kirkstall Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 93. Kirkstall Recent Developments/Updates
 Table 94. Kirkstall Competitive Strengths & Weaknesses
 Table 95. Cherry Biotech SAS Basic Information, Manufacturing Base and Competitors
 Table 96. Cherry Biotech SAS Major Business
 Table 97. Cherry Biotech SAS Human Organs-on-Chips Product and Services
 Table 98. Cherry Biotech SAS Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 99. Cherry Biotech SAS Recent Developments/Updates
 Table 100. Cherry Biotech SAS Competitive Strengths & Weaknesses
 Table 101. Else Kooi Laboratory Basic Information, Manufacturing Base and Competitors
 Table 102. Else Kooi Laboratory Major Business
 Table 103. Else Kooi Laboratory Human Organs-on-Chips Product and Services
 Table 104. Else Kooi Laboratory Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 105. Else Kooi Laboratory Recent Developments/Updates
 Table 106. Else Kooi Laboratory Competitive Strengths & Weaknesses
 Table 107. Altis Biosystems Basic Information, Manufacturing Base and Competitors
 Table 108. Altis Biosystems Major Business
 Table 109. Altis Biosystems Human Organs-on-Chips Product and Services
 Table 110. Altis Biosystems Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 111. Altis Biosystems Recent Developments/Updates
 Table 112. Altis Biosystems Competitive Strengths & Weaknesses
 Table 113. Bi/ond Basic Information, Manufacturing Base and Competitors
 Table 114. Bi/ond Major Business
 Table 115. Bi/ond Human Organs-on-Chips Product and Services
 Table 116. Bi/ond Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 117. Bi/ond Recent Developments/Updates
 Table 118. Bi/ond Competitive Strengths & Weaknesses
 Table 119. Netri Basic Information, Manufacturing Base and Competitors
 Table 120. Netri Major Business
 Table 121. Netri Human Organs-on-Chips Product and Services
 Table 122. Netri Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 123. Netri Recent Developments/Updates
 Table 124. Netri Competitive Strengths & Weaknesses
 Table 125. Xona Microfluidics Basic Information, Manufacturing Base and Competitors
 Table 126. Xona Microfluidics Major Business
 Table 127. Xona Microfluidics Human Organs-on-Chips Product and Services
 Table 128. Xona Microfluidics Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 129. Xona Microfluidics Recent Developments/Updates
 Table 130. Xona Microfluidics Competitive Strengths & Weaknesses
 Table 131. SynVivo Basic Information, Manufacturing Base and Competitors
 Table 132. SynVivo Major Business
 Table 133. SynVivo Human Organs-on-Chips Product and Services
 Table 134. SynVivo Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 135. SynVivo Recent Developments/Updates
 Table 136. SynVivo Competitive Strengths & Weaknesses
 Table 137. Beijing Daxiang Biotech Basic Information, Manufacturing Base and Competitors
 Table 138. Beijing Daxiang Biotech Major Business
 Table 139. Beijing Daxiang Biotech Human Organs-on-Chips Product and Services
 Table 140. Beijing Daxiang Biotech Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 141. Beijing Daxiang Biotech Recent Developments/Updates
 Table 142. Beijing Daxiang Biotech Competitive Strengths & Weaknesses
 Table 143. AVATARGET Basic Information, Manufacturing Base and Competitors
 Table 144. AVATARGET Major Business
 Table 145. AVATARGET Human Organs-on-Chips Product and Services
 Table 146. AVATARGET Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 147. AVATARGET Recent Developments/Updates
 Table 148. AVATARGET Competitive Strengths & Weaknesses
 Table 149. Suzhou Jiyan Biopharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 150. Suzhou Jiyan Biopharmaceutical Major Business
 Table 151. Suzhou Jiyan Biopharmaceutical Human Organs-on-Chips Product and Services
 Table 152. Suzhou Jiyan Biopharmaceutical Human Organs-on-Chips Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
 Table 153. Suzhou Jiyan Biopharmaceutical Recent Developments/Updates
 Table 154. Suzhou Jiyan Biopharmaceutical Competitive Strengths & Weaknesses
 Table 155. Global Key Players of Human Organs-on-Chips Upstream (Raw Materials)
 Table 156. Global Human Organs-on-Chips Typical Customers


List of Figures
 Figure 1. Human Organs-on-Chips Picture
 Figure 2. World Human Organs-on-Chips Total Revenue: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Human Organs-on-Chips Total Revenue (2019-2030) & (USD Million)
 Figure 4. World Human Organs-on-Chips Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
 Figure 5. World Human Organs-on-Chips Revenue Market Share by Region (2019-2030), (by Headquarter Location)
 Figure 6. United States Based Company Human Organs-on-Chips Revenue (2019-2030) & (USD Million)
 Figure 7. China Based Company Human Organs-on-Chips Revenue (2019-2030) & (USD Million)
 Figure 8. Europe Based Company Human Organs-on-Chips Revenue (2019-2030) & (USD Million)
 Figure 9. Japan Based Company Human Organs-on-Chips Revenue (2019-2030) & (USD Million)
 Figure 10. South Korea Based Company Human Organs-on-Chips Revenue (2019-2030) & (USD Million)
 Figure 11. ASEAN Based Company Human Organs-on-Chips Revenue (2019-2030) & (USD Million)
 Figure 12. India Based Company Human Organs-on-Chips Revenue (2019-2030) & (USD Million)
 Figure 13. Human Organs-on-Chips Market Drivers
 Figure 14. Factors Affecting Demand
 Figure 15. World Human Organs-on-Chips Consumption Value (2019-2030) & (USD Million)
 Figure 16. World Human Organs-on-Chips Consumption Value Market Share by Region (2019-2030)
 Figure 17. United States Human Organs-on-Chips Consumption Value (2019-2030) & (USD Million)
 Figure 18. China Human Organs-on-Chips Consumption Value (2019-2030) & (USD Million)
 Figure 19. Europe Human Organs-on-Chips Consumption Value (2019-2030) & (USD Million)
 Figure 20. Japan Human Organs-on-Chips Consumption Value (2019-2030) & (USD Million)
 Figure 21. South Korea Human Organs-on-Chips Consumption Value (2019-2030) & (USD Million)
 Figure 22. ASEAN Human Organs-on-Chips Consumption Value (2019-2030) & (USD Million)
 Figure 23. India Human Organs-on-Chips Consumption Value (2019-2030) & (USD Million)
 Figure 24. Producer Shipments of Human Organs-on-Chips by Player Revenue ($MM) and Market Share (%): 2023
 Figure 25. Global Four-firm Concentration Ratios (CR4) for Human Organs-on-Chips Markets in 2023
 Figure 26. Global Four-firm Concentration Ratios (CR8) for Human Organs-on-Chips Markets in 2023
 Figure 27. United States VS China: Human Organs-on-Chips Revenue Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Human Organs-on-Chips Consumption Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. World Human Organs-on-Chips Market Size by Type, (USD Million), 2019 & 2023 & 2030
 Figure 30. World Human Organs-on-Chips Market Size Market Share by Type in 2023
 Figure 31. Brain-on-a-chip
 Figure 32. Liver-on-a-chip
 Figure 33. Kidney-on-a-chip
 Figure 34. Lung-on-a-chip
 Figure 35. Heart-on-a-chip
 Figure 36. Intestine-on-a-chip
 Figure 37. Vessel-on-a-chip
 Figure 38. Other Organs
 Figure 39. Vessel-on-a-chip
 Figure 40. World Human Organs-on-Chips Market Size Market Share by Type (2019-2030)
 Figure 41. World Human Organs-on-Chips Market Size by End User, (USD Million), 2019 & 2023 & 2030
 Figure 42. World Human Organs-on-Chips Market Size Market Share by End User in 2023
 Figure 43. Pharmaceutical & Biotechnology Companies
 Figure 44. Academic & Research Institutes
 Figure 45. Cosmetics Industry
 Figure 46. Others
 Figure 47. World Human Organs-on-Chips Market Size Market Share by End User (2019-2030)
 Figure 48. Human Organs-on-Chips Industrial Chain
 Figure 49. Methodology
 Figure 50. Research Process and Data Source

Companies Mentioned

Emulate
Mimetas
TissUse
Valo Health
CN Bio Innovations
Hesperos
Draper Laboratory
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
Altis Biosystems
Bi/ond
Netri
Xona Microfluidics
SynVivo
Beijing Daxiang Biotech
AVATARGET
Suzhou Jiyan Biopharmaceutical